These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3885396)

  • 41. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new H-2-linked class I gene whose expression depends on a maternally inherited factor.
    Lindahl KF; Hausmann B; Chapman VM
    Nature; 1983 Nov 24-30; 306(5941):383-5. PubMed ID: 6646216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Organization and expression of the MHC of the C57 black/10 mouse.
    Flavell RA; Allen H; Huber B; Wake C; Widera G
    Immunol Rev; 1985 Jul; 84():29-50. PubMed ID: 3899909
    [No Abstract]   [Full Text] [Related]  

  • 44. Deletion of high-avidity T cells by thymic epithelium.
    Hoffmann MW; Heath WR; Ruschmeyer D; Miller JF
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9851-5. PubMed ID: 7568231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic control of transplant rejection.
    Butcher GW; Howard JC
    Transplantation; 1982 Oct; 34(4):161-6. PubMed ID: 6815843
    [No Abstract]   [Full Text] [Related]  

  • 46. Mechanism of the rejection of major histocompatibility complex class I-disparate murine skin grafts: rejection can be mediated by CD4+ cells activated by allo-class I + II antigen in CD8+ cell-depleted hosts.
    Kobayashi E; Kawai K; Ikarashi Y; Fujiwara M
    J Exp Med; 1992 Aug; 176(2):617-21. PubMed ID: 1354244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rejection of islets differing by a single antigen is dependent on donor MHC.
    Vigneau-Hermellin M; Vitali L; Tardivel I; Rabaud M; Holers MV; Carel JC
    Diabetes; 1997 May; 46(5):765-9. PubMed ID: 9133542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic mapping in the major histocompatibility complex by restriction enzyme site polymorphisms: most mouse class I genes map to the Tla complex.
    Winoto A; Steinmetz M; Hood L
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3425-9. PubMed ID: 6304710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
    Held W; Cado D; Raulet DH
    J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence that the effector mechanism of skin allograft rejection is antigen-specific.
    Rosenberg AS; Singer A
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7739-42. PubMed ID: 2459716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog.
    Hunziker RD; Lynch F; Shevach EM; Margulies DH
    Hum Immunol; 1997 Feb; 52(2):82-94. PubMed ID: 9077557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
    Rosenberg AS; Munitz TI; Maniero TG; Singer A
    J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular immunology of allograft rejection: insights from MHC mutants and crystal structure.
    DiSesa VJ
    J Heart Lung Transplant; 1991; 10(1 Pt 1):111-6. PubMed ID: 2007162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeted correction of a major histocompatibility class II E alpha gene by DNA microinjected into mouse eggs.
    Brinster RL; Braun RE; Lo D; Avarbock MR; Oram F; Palmiter RD
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7087-91. PubMed ID: 2506546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular biology of the H-2 histocompatibility complex.
    Flavell RA; Allen H; Burkly LC; Sherman DH; Waneck GL; Widera G
    Science; 1986 Jul; 233(4762):437-43. PubMed ID: 3726537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection.
    Grigoriadou K; Ménard C; Pérarnau B; Lemonnier FA
    Eur J Immunol; 1999 Nov; 29(11):3683-90. PubMed ID: 10556824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
    Hui KM; Sim T; Foo TT; Oei AA
    J Immunol; 1989 Dec; 143(11):3835-43. PubMed ID: 2584720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Spontaneous mutation of the H-2b-haplotype in C57BL/10SnY mice].
    Blandova ZK; Rat'kin AE
    Genetika; 1987 Jul; 23(7):1334-6. PubMed ID: 3308634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid gene.
    Sun YH; Goodenow RS; Hood L
    J Exp Med; 1985 Nov; 162(5):1588-602. PubMed ID: 2997361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.